Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107.

Article  PubMed  Google Scholar 

Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393–409.

Article  PubMed  Google Scholar 

Chadban S, Arıcı M, Power A, et al. Projecting the economic burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. eClinicalMedicine.

Chertow GM, Correa-Rotter R, Eckardt K-U, et al. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. eClinicalMedicine.

Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–46.

Article  CAS  PubMed  Google Scholar 

The Empa-Kidney Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117–27.

Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219–29.

Article  CAS  PubMed  Google Scholar 

Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391:109.

Article  PubMed  Google Scholar 

Fernández-Fernandez B, Sarafidis P, Soler MJ, et al. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors. Clin Kidney J. 2023;16(8):1187–98.

Article  PubMed  PubMed Central  Google Scholar 

Vart P, Vaduganathan M, Jongs N, et al. Estimated lifetime benefit of combined RAAS and SGLT2 inhibitor therapy in patients with albuminuric CKD without diabetes. Clin J Am Soc Nephrol. 2022;17(12):1754–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McEwan P, Gabb PD, Davis JA, et al. The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis. Nephrol Dial Transpl. 2024.

Heerspink HJL, Vart P, Jongs N, et al. Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: a joint analysis of randomized controlled clinical trials. Diabetes Obes Metab. 2023;25(11):3327–36.

Article  CAS  PubMed  Google Scholar 

Neuen BL, Heerspink HJL, Vart P, et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024;149(6):450–62.

Article  CAS  PubMed  Google Scholar 

Jesky MD, Dutton M, Dasgupta I, et al. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLoS ONE. 2016;11(11): e0165675.

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Garcia G, Chavez-Iñiguez JS. The tragedy of having ESRD in Mexico. Kidney Int Rep. 2018;3(5):1027–9.

Article  PubMed  PubMed Central  Google Scholar 

Markossian TW, Classen T. The financial burden of inadequate health insurance coverage. Am J Kidney Dis. 2021;78(5):627–9.

Article  PubMed  Google Scholar 

Alshammari B, Noble H, McAneney H, et al. Factors associated with burden in caregivers of patients with end-stage kidney disease (a systematic review). Healthcare (Basel). 2021;9(9):1212.

Article  PubMed  PubMed Central  Google Scholar 

Ania-González N, Martín-Martín J, Amezqueta-Goñi P, et al. The needs of families who care for individuals with kidney failure on comprehensive conservative care: a qualitative systematic review. J Ren Care. 2022;48(4):230–42.

Article  PubMed  PubMed Central  Google Scholar 

Kent S, Schlackow I, Lozano-Kühne J, et al. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol. 2015;16:65.

Article  PubMed  PubMed Central  Google Scholar 

Damien P, Lanham HJ, Parthasarathy M, et al. Assessing key cost drivers associated with caring for chronic kidney disease patients. BMC Health Serv Res. 2016;16(1):690.

Article  PubMed  PubMed Central  Google Scholar 

United States Renal Data System. Annual Data Report: Epidemiology of kidney disease in the United States. 2023. https://usrds-adr.niddk.nih.gov/2023. Accessed 04 Jan 2024.

Roberts G, Holmes J, Williams G, et al. Current costs of dialysis modalities: a comprehensive analysis within the United Kingdom. Perit Dial Int. 2022;42(6):578–84.

Article  PubMed  Google Scholar 

Kidney Research UK. Kidney disease: A UK public health emergency. The health economics of kidney disease to 2033. 2023. https://www.kidneyresearchuk.org/wp-content/uploads/2023/06/Economics-of-Kidney-Disease-full-report_accessible.pdf. Accessed 28 Feb 2024.

Morton JI, McDonald SP, Salim A, et al. Projecting the incidence of type 2 diabetes-related end-stage kidney disease until 2040: a comparison between the effects of diabetes prevention and the effects of diabetes treatment. Diabetes Care. 2021;44(7):1515–23.

Article  PubMed  Google Scholar 

Carriazo S, Ortiz A. The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe. Clin Kidney J. 2022;15(3):393–6.

Article  PubMed  Google Scholar 

UK Kidney Association. UK Renal Registry: 25th Annual Report. 2023. https://ukkidney.org/audit-research/annual-report. Accessed 05 July 2023.

Canaud B, Tong L, Tentori F, et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2011;6(7):1651–62.

Article  PubMed  PubMed Central  Google Scholar 

Cozzolino M, Mangano M, Stucchi A, et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transpl. 2018;33(suppl_3):iii28–iii34.

Lee AJ, Morgan CL, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin. 2005;21(11):1777–83.

Article  PubMed  Google Scholar 

Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.

Article  PubMed  PubMed Central  Google Scholar 

NHS Improving Quality. End of life care in advanced kidney disease: a framework for implementation. 2017. https://www.england.nhs.uk/improvement-hub/wp-content/uploads/sites/44/2017/11/Advanced-kidney-disease.pdf. Accessed 28 Apr 2022.

Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ. 2012;184(5):E277–83.

Article  PubMed  PubMed Central  Google Scholar 

Jassal SV, Chow E. Age-old musings: twenty-first century management of advanced kidney disease in older individuals. Nat Rev Nephrol. 2022;18(1):1–2.

Article  PubMed  Google Scholar 

Buur LE, Madsen JK, Eidemak I, et al. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review. BMC Nephrol. 2021;22(1):307.

Article  PubMed  Google Scholar 

O’Connor NR, Kumar P. Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med. 2012;15(2):228–35.

Article  PubMed  PubMed Central  Google Scholar 

National Institute for Health and Care Excellence. Renal replacement therapy and conservative management [NG107]. 2018. https://www.nice.org.uk/guidance/ng107. Accessed 24 Oct 2022.

van Oevelen M, Abrahams AC, Bos WJW, et al. DIALysis or not: outcomes in older kidney patients with GerIatriC Assessment (DIALOGICA): rationale and design. BMC Nephrol. 2021;22(1):39.

Article  PubMed  PubMed Central  Google Scholar 

Murphy E, Burns A, Murtagh FEM, et al. The Prepare for Kidney Care Study: prepare for renal dialysis versus responsive management in advanced chronic kidney disease. Nephrol Dial Transpl. 2021;36(6):975–82.

Article  Google Scholar 

Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transpl. 2011;11(10):2093–109.

Article  CAS  Google Scholar 

Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.

Article  PubMed